Pharmacokinetics and Tumor Targeting of 131I-Labeled F(ab')2 Fragments of the Chimeric Monoclonal Antibody G250: Preclinical and Clinical Pilot Studies
- 1 August 2004
- journal article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 19 (4) , 466-477
- https://doi.org/10.1089/1084978041979607
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: